• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌中预后替代信使 RNA 剪接特征和剪接因子的系统谱分析。

Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.

机构信息

1 Shandong Provincial Key Laboratory of Oral Tissue Regeneration, School of Stomatology, Shandong University, Jinan, China.

2 Department of Stomatology, Haiyuan College of Kunming Medical University, Kunming, China.

出版信息

DNA Cell Biol. 2019 Jul;38(7):627-638. doi: 10.1089/dna.2019.4644. Epub 2019 Apr 26.

DOI:10.1089/dna.2019.4644
PMID:31025877
Abstract

Head and neck squamous cell carcinoma (HNSC) is a common malignancy with high mortality and poor prognosis. Alternative splicing (AS) is a transcriptional regulation mechanism that generates multiple transcripts from same genes, and aberrant AS signatures of cancers can be predictive for prognosis. We identified the survival-related AS events and splicing factors (SFs) from the RNA sequencing data and the corresponding clinical information of an HNSC cohort downloaded from The Cancer Genome Atlas (TCGA) and SpliceSeq. The independent prognostic predictors were assessed by Cox proportional regression analysis, and the regulatory network of SFs and AS events was analyzed by Spearman's test and constructed. A total of 4626 survival-related AS events in 3280 genes were identified, and most were protective factors. Among the different types of splicing events, exon skip was the most frequent. The prognostic models were constructed for each type of AS, and the area under the curve of the receiver operating characteristic curve of the combined prognostic model was 0.765, indicating good predictive performance. Finally, a correlation network between SF and AS events was constructed. We identified prognostic predictors based on AS events that stratified HNSC patients into the high- and low-risk groups, and revealed splicing networks that provide insights into the underlying mechanisms.

摘要

头颈部鳞状细胞癌(HNSC)是一种常见的恶性肿瘤,死亡率高,预后差。可变剪接(AS)是一种转录调控机制,它能从同一基因产生多个转录本,而癌症的异常 AS 特征可用于预测预后。我们从 HNSC 队列的 RNA 测序数据和从癌症基因组图谱(TCGA)和 SpliceSeq 下载的相应临床信息中鉴定了与生存相关的 AS 事件和剪接因子(SF)。通过 Cox 比例风险回归分析评估独立预后预测因子,并通过 Spearman 检验和构建分析 SF 和 AS 事件的调控网络。在 3280 个基因中鉴定了 4626 个与生存相关的 AS 事件,其中大多数是保护因素。在不同类型的剪接事件中,外显子跳跃最为常见。为每种类型的 AS 构建了预后模型,联合预后模型的受试者工作特征曲线下面积为 0.765,表明具有良好的预测性能。最后,构建了 SF 和 AS 事件之间的相关网络。我们基于 AS 事件确定了预后预测因子,这些预测因子将 HNSC 患者分为高风险和低风险组,并揭示了剪接网络,为潜在机制提供了见解。

相似文献

1
Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌中预后替代信使 RNA 剪接特征和剪接因子的系统谱分析。
DNA Cell Biol. 2019 Jul;38(7):627-638. doi: 10.1089/dna.2019.4644. Epub 2019 Apr 26.
2
Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.全面描绘头颈部鳞状细胞癌中的可变剪接全景,揭示与肿瘤发生和免疫微环境相关的新事件。
Theranostics. 2019 Oct 14;9(25):7648-7665. doi: 10.7150/thno.36585. eCollection 2019.
3
Characterization of alternative splicing events and prognostic signatures in breast cancer.乳腺癌中可变剪接事件和预后特征的分析。
BMC Cancer. 2021 May 22;21(1):587. doi: 10.1186/s12885-021-08305-6.
4
Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.肺腺癌中预后替代剪接特征和剪接因子的全基因组分析。
Genes (Basel). 2020 Oct 31;11(11):1300. doi: 10.3390/genes11111300.
5
Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.口腔鳞状细胞癌中预后性可变剪接标志的鉴定。
J Cell Physiol. 2020 May;235(5):4804-4813. doi: 10.1002/jcp.29357. Epub 2019 Oct 21.
6
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.基于317例样本的剪接序列数据构建膀胱尿路上皮癌可变剪接事件的预后特征
Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.
7
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.系统分析剪接变异特征揭示了肾透明细胞癌的预后预测因子。
J Cell Physiol. 2019 Dec;234(12):22753-22764. doi: 10.1002/jcp.28840. Epub 2019 May 29.
8
Prognostic alternative mRNA splicing signature in non-small cell lung cancer.非小细胞肺癌中的预后性可变mRNA剪接特征
Cancer Lett. 2017 May 1;393:40-51. doi: 10.1016/j.canlet.2017.02.016. Epub 2017 Feb 20.
9
Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.基于 TCGA SpliceSeq 数据鉴定肾上腺皮质癌中与生存相关的可变剪接事件和特征。
Aging (Albany NY). 2020 Mar 26;12(6):4996-5009. doi: 10.18632/aging.102924.
10
Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.基于 TCGA SpliceSeq 数据的异常 mRNA 剪接谱预后指数可作为肝细胞癌的预测指标。
Int J Oncol. 2019 Aug;55(2):425-438. doi: 10.3892/ijo.2019.4834. Epub 2019 Jun 27.

引用本文的文献

1
Alternative Splicing Landscape of Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌的可变剪接图谱
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241272051. doi: 10.1177/15330338241272051.
2
Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features.剪接 machinery 是在口腔鳞状细胞 carcinoma 中受损,并与关键的病理生理特征有关。
Int J Mol Sci. 2024 Jun 25;25(13):6929. doi: 10.3390/ijms25136929.
3
Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development.
用于mRNA疫苗开发的头颈部鳞状细胞癌肿瘤抗原和免疫亚型的鉴定
Front Cell Dev Biol. 2022 Nov 17;10:1064754. doi: 10.3389/fcell.2022.1064754. eCollection 2022.
4
Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma.可变剪接预后特征的构建揭示了头颈部鳞状细胞癌的预后预测指标和免疫微环境。
Front Genet. 2022 Oct 21;13:989081. doi: 10.3389/fgene.2022.989081. eCollection 2022.
5
Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma.TACC1变体25缺失诱导头颈部鳞状细胞癌的细胞增殖并抑制自噬。
Cell Death Discov. 2021 Dec 11;7(1):386. doi: 10.1038/s41420-021-00777-6.
6
Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.可变剪接——化疗中癌细胞的特洛伊木马。
Genes (Basel). 2021 Jul 18;12(7):1085. doi: 10.3390/genes12071085.
7
Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.头颈部鳞状细胞癌的遗传驱动因素:异常剪接事件、突变负担、HPV 感染和未来的靶点。
Genes (Basel). 2021 Mar 15;12(3):422. doi: 10.3390/genes12030422.
8
Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.肺腺癌中预后替代剪接特征和剪接因子的全基因组分析。
Genes (Basel). 2020 Oct 31;11(11):1300. doi: 10.3390/genes11111300.
9
Identification of an alternative splicing signature as an independent factor in colon cancer.鉴定剪接变异标志作为结肠癌的一个独立因素。
BMC Cancer. 2020 Sep 22;20(1):904. doi: 10.1186/s12885-020-07419-7.
10
Silencing lncRNA HOXA10-AS decreases cell proliferation of oral cancer and HOXA10-antisense RNA can serve as a novel prognostic predictor.沉默长链非编码 RNA HOXA10-AS 可降低口腔癌细胞增殖,HOXA10-反义 RNA 可作为一种新的预后预测因子。
J Int Med Res. 2020 Aug;48(8):300060520934254. doi: 10.1177/0300060520934254.